FIBERCON (Wyeth Pharmaceutical Division of Wyeth Holdings Corporation, a subsidiary of Pfizer Inc.)
Welcome to the PulseAid listing for the FIBERCON drug offered from Wyeth Pharmaceutical Division of Wyeth Holdings Corporation, a subsidiary of Pfizer Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Wyeth Pharmaceutical Division of Wyeth Holdings Corporation, a subsidiary of Pfizer Inc. |
NON-PROPRIETARY NAME: | CALCIUM POLYCARBOPHIL |
SUBSTANCE NAME: | CALCIUM POLYCARBOPHIL |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2004-01-05 |
END MARKETING DATE: | 0000-00-00 |
FIBERCON HUMAN OTC DRUG Details:
Item Description | FIBERCON from Wyeth Pharmaceutical Division of Wyeth Holdings Corporation, a subsidiary of Pfizer Inc. |
LABELER NAME: | Wyeth Pharmaceutical Division of Wyeth Holdings Corporation, a subsidiary of Pfizer Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 625(mg/1) |
START MARKETING DATE: | 2004-01-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0005-2500_ffb6c98d-e53e-474b-a4c6-1bc7f02b90bb |
PRODUCT NDC: | 0005-2500 |
APPLICATION NUMBER: | part334 |
Other CALCIUM POLYCARBOPHIL Pharmaceutical Manufacturers / Labelers: